Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Represents 100,500 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date.

Represents 130,617 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's IPO and which have no expiration date.

The options were granted initially as the right to buy Nonvoting Common Stock. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock, for the same price and under the same conditions.

The options are fully vested.


On August 15, 2025, the reporting person was awarded 27,400 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 13,700 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.


Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 5, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.

The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.

The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.

EVP, Chief Commercial & Strategy Officer

/s/ Thomas J. DesRosier, attorney-in-fact for Teresa L. Young


On August 15, 2025, the reporting person was awarded 15,223 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 7,612 units and 7,611 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.

The shares of common stock are held directly by Concord International, Inc.  The reporting person is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.


Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Includes 46,875 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date. Of his 46,875 shares of Nonvoting Common Stock, (i) 15,375 are held in his individual name and (ii) 31,500 are held jointly with his spouse with right of survivorship

The options are fully vested

/s/Alessandra Maria Corona Henriques, Attorney-in-Fact


Title: Chief Administrative and Legal Officer and Secretary


Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest 25% quarterly, such that the RSUs will vest completely on the first anniversary of the date of grant. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan.

/s/ Kris Kang, attorney in fact for Robin Pederson


Common Stock

The option exercise and sale of shares of common stock of Intapp, Inc. was executed pursuant to a 10b5-1 plan put in place by the Reporting Person on September 13, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from (a) with respect to the weighted average price of $41.8689: $41.69 to $41.99, inclusive, (b) with respect to the weighted average price of $42.5607: $42.00 to $42.99, inclusive, and (c) with respect to the weighted average price of $43.0964: $43.00 to $43.22, inclusive. The reporting person undertakes to provide to Intapp, Inc., any security holder of Intapp, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

The shares underlying this option are fully vested and exercisable as of the date hereof.


On August 15, 2025, the reporting person was awarded 33,991 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 16,996 units and 16,995 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.

These shares of common stock are jointly owned by the reporting person and his spouse.


Common Stock

Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonqualified Stock Option (Right to Buy)

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Represents 500 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date.

Mr. Gallagher maintains beneficial ownership, including dispositive and voting control, over Gallagher Investments, LLC

Represents 573,963 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's IPO and which have no expiration date.

Includes 12,000 shares of common stock jointly with his spouse with right of survival

Represents 135,395 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's IPO and which have no expiration date.

The options were granted initially as the right to buy Nonvoting Common Stock. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock, for the same price and under the same conditions.

The options are fully vested.


On August 15, 2025, the reporting person was awarded 19,524 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 9,762 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.


Blackstone Real Estate Income Trust, Inc.

Beier Raymond J.

C/O BLACKSTONE REAL ESTATE INCOME TRUST,

Reflects a grant of restricted stock that vests on August 15, 2026.

Includes shares acquired through the Issuer's Distribution Reinvestment Plan.


Common Stock

In connection with the vesting on August 16, 2025, of 1,354 restricted stock units previously granted to the reporting person, the reporting person's receipt of 1,354 shares of common stock was deferred resulting in the reporting person's receipt instead of 1,354 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 1,354 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.


Common Stock

Common Stock

Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Nonvoting Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Includes 30,000 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and which have no expiration date.

Includes 31,242 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and which have no expiration date.

Includes 30,000 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and which have no expiration date, and which are held in the estate of Byrum W. Teekell for which J. Gray Teekell is executor and disclaims beneficial ownership as to 22,500 shares of Common Stock The inclusion of such 22,500 shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.

Includes 38,131 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and which have no expiration date, which are held in the estate of Byrum W. Teekell for which J. Gray Teekell is executor and disclaims beneficial ownership as to 28,599 shares of Common Stock. The inclusion of such 28,599 shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.

The options were granted initially as the right to buy Nonvoting Common Stock. On the closing date of the initial public offering, these converted to the right to buy Common Stock instead of Nonvoting Common Stock, for the same price and under the same conditions.

The options are fully vested.


On August 15, 2025, the reporting person was awarded 24,031 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 12,016 units and 12,015 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Includes dividend equivalents accrued during the performance period that are subject to the same performance-based and time-based vesting conditions as the underlying cash-settled performance stock units.

The cash-settled performance stock units were deemed to have settled for an equivalent number of shares of News Corporation's Class A Common Stock.

Represents shares withheld upon vesting of applicable incentive award to satisfy tax withholding obligations.

Includes dividend equivalents accrued during the vesting period that are subject to the same time-based vesting conditions as the underlying cash-settled restricted stock units.

The cash-settled restricted stock units were deemed to have settled for an equivalent number of shares of News Corporation's Class A Common Stock.

Each cash-settled performance stock unit is the economic equivalent of one share of News Corporation's Class A Common Stock.

Each cash-settled restricted stock unit is the economic equivalent of one share of News Corporation's Class A Common Stock.

The cash-settled restricted stock units were granted as part of the Reporting Person's fiscal 2026 long-term equity incentive award.

The cash-settled restricted stock units will vest in thirds on August 15, 2026, 2027 and 2028, subject to time-based vesting conditions.

/s/ Kenneth C. Mertz as Attorney-in-Fact for Robert J. Thomson


On August 15, 2025, the reporting person was awarded 17,424 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs are earned in six approximately equal monthly installments commencing on August 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.


/s/ Lindsey Christen, as Attorney-in-Fact for Thomas E. Kirn


Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest 25% quarterly, such that the RSUs will vest completely on the first anniversary of the date of grant. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan.

/s/ Kris Kang, attorney-in-fact to Andres Reiner


/s/ Craig D. Apolinsky, Attorney-in-Fact for William Forrest Bell


Includes: (i) 1,650 shares held by The Weinstein Foundation, a private foundation for which the Reporting Person acts as a trustee and has shared investment and voting power; (ii) 392,538 shares directly owned by the Reporting Person; (iii) 35,000 shares directly owned by the Reporting Person and are held in an IRA; and (iv) 400,000 shares beneficially owned indirectly by the Reporting Person through a limited liability company for the benefit of certain family members of the Reporting Person, in which the Reporting Person has a 10% interest and sole voting power and does not include 6,250 shares issuable to the reporting person pursuant to stock options that are currently exercisable.

The Reporting Person has a 50% interest (115,273 shares) with respect to the securities held in this limited liability company.


Class A Common Stock

Class A Common Stock

Class A Common Stock

/s/ Kenneth C. Mertz as Attorney-in-Fact for Keith Rupert Murdoch


Singisetti Ravi Kumar

C/O COGNIZANT TECHNOLOGY SOLUTIONS CORP.

Class A Common Stock

Shares of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company") received from the vesting of 1/12th of the restricted stock unit ("RSU") award granted on February 16, 2023.

Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.

Shares of the Company's Class A Common Stock withheld to pay applicable taxes.

A total of 69,318 RSUs were originally granted on February 16, 2023, under the Company's 2017 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over three years, commencing on May 16, 2023, with 1/12th of such RSUs vesting on each quarterly vesting date so that such RSUs will be fully vested on the twelfth quarterly vesting date (February 16, 2026).

/s/ Kelli Arman, on behalf of Ravi Kumar Singisetti, by Power of Attorney


This form is filed jointly by each of the reporting persons listed above. Joseph La Rosa and Deana La Rosa, Issuer's Chief Operating Officer, are husband and wife. Mr. La Rosa owns the shares of common stock directly and Mrs. La Rosa owns them indirectly as Mr. La Rosa's spouse.

Represents a single issuance of shares of restricted common stock of the Issuer to Mr. La Rosa, vesting on the date of the grant, pursuant to the Second Amended and Restated La Rosa Holdings Corp. 2022 Equity Incentive Plan.

Represents a single issuance of shares of restricted common stock of the Issuer to Mrs. La Rosa, vesting on the date of the grant, pursuant to the Second Amended and Restated La Rosa Holdings Corp. 2022 Equity Incentive Plan

Owned by JLR-JCCLT1 Land Trust, controlled by Mr. Joseph La Rosa. Mr. Joseph La Rosa is the trustee of the trust.

Owned by Celebration Office Condos, LLC, a company owned and controlled by Joseph La Rosa.


Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Includes 17,500 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and which have no expiration date.

Includes 26,327 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and which have no expiration date.

The options were granted initially as the right to buy Nonvoting Common Stock. On the closing date of the initial public offering, these converted to the right to buy Common Stock instead of Nonvoting Common Stock, for the same price and under the same conditions.

The options are fully vested.


/s/ Lindsey Christen, as Attorney-in-Fact for Matthew D. Wagner


The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP").

In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025.


Represents a restricted stock award originally granted to the Reporting Person on March 23, 2025 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended ("2022 Plan" and the grant on such date, the "Original Award"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified.

On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis.

Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.


Represents a restricted stock award originally granted to the Reporting Person on September 26, 2024 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended ("2022 Plan" and the grant on such date, the "Original Award"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified.


Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Nonvoting Common Stock

Common Stock

Includes 36,250 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date.

Includes 45,058 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's IPO and which have no expiration date.

The options were granted initially as the right to buy Nonvoting Common Stock. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock, for the same price and under the same conditions.

The options are fully vested.


These transactions occurred pursuant to broker-dealer sales conducted in accordance with Rule 144 under the Securities Act of 1933, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.99, inclusive. The Reporting Persons (as defined below) undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.99, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.98, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.995, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.99, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.99, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.00 to $86.07, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.

This report is filed jointly by Weichai America Corp., Weichai Power Co., Ltd. and Shandong Heavy Industry Group Co., Ltd. (collectively, the "Reporting Persons"). Weichai America Corp. is the direct owner of the Common Stock referenced in this report and shares the power to vote and the power to dispose of all of such shares of Common Stock with the other Reporting Persons. No individual has beneficial ownership over the Common Stock beneficially owned by the Reporting Persons.

Exhibit List:
Exhibit 24.1 - Power of Attorney (Weichai Power Co., Ltd.), incorporated by reference to Exhibit 24.1 to the Form 4 filed by Reporting Persons with the Securities and Exchange Commission on August 14, 2025
Exhibit 24.2 - Power of Attorney (Shandong Heavy Industry Group Co., Ltd.), incorporated by reference to Exhibit 24.2 to the Form 4 filed by Reporting Persons with the Securities and Exchange Commission on August 14, 2025


Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest 25% quarterly, such that the RSUs will vest completely on the first anniversary of the date of grant. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan.

/s/ Kris Kang, attorney-in-fact to Kenneth B. Robinson


On August 15, 2025, the reporting person was awarded 12,507 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 6,254 units and 6,253 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of SPGI common stock.

The reporting person was granted 3,569 restricted stock units on 8/15/2025, subject to 3-year cliff vesting. The restricted stock units will vest 100% on 8/15/2028.

As previously reported, these restricted stock units were converted from restricted stock units in IHS Markit Ltd. ("IHS Markit") in connection with the IHS Markit merger, and have the same terms and conditions as those that applied immediately prior to the consummation of the merger, except that the performance-vesting conditions with respect to the restricted stock units that were converted from IHS Markit performance-based restricted stock units lapsed.

As previously reported, the reporting person acquired 11,124 restricted stock units on 03/04/2025 upon satisfaction of the performance criteria for a performance-based restricted stock unit award issued on 05/03/2022.  The time-based restricted stock units in respect of the award vested 33% on 12/31/2024 and will vest 33% on 12/31/2025 and 34% on 12/31/2026. Vested shares for outstanding award tranches will be delivered to the reporting person no later than January 31 following the respective service-based vesting date.

As previously reported, the reporting person was granted 444 restricted stock units on 03/01/2023, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2023 and 33% on 12/31/20243 and the remaining 34% will vest on 12/31/2025. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.

As previously reported, the reporting person was granted 349 restricted stock units on 03/01/2024, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2024 and will vest 33% on 12/31/2025 and 34% on 12/31/2026. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.

As previously reported, the reporting person was granted 392 restricted stock units on 03/01/2025, subject to 3-year vesting. The restricted stock units will vest 33% on 12/31/2025, 33% on 12/31/2026 and 34% on 12/31/2027. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.


On August 15, 2025, the reporting person was awarded 9,727 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 4,864 units and 4,863 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.

These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners").  Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.


MAZ Capital Advisors, LLC is the General Partner of MAZ Partners LP, and the reporting person is the sole member and manager of MAZ Capital Advisors, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

/s/ Phillip Podgorski, attorney-in-fact for Walter Schenker


Class A Common Stock

Class A Common Stock

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan that was adopted on March 8, 2025.

This sale price represents the weighted average sale price of the shares sold ranging from $244.43 to $245.33 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $245.44 to $246.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $246.44 to $247.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $247.44 to $248.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $248.44 to $249.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $250.00 to $250.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The shares are held by The Article 4 Trust under TXX Family Trust for which the Reporting Person serves as a trustee.

The shares underlying the option are fully vested and immediately exercisable.

/s/ Kimberly Hackman, by power of attorney


By Jessica P. Sarowitz Declaration of Trust

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest 25% quarterly, such that the RSUs will vest completely on the first anniversary of the date of grant. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan.

/s/ Kris Kang, attorney-in-fact to Steven I. Sarowitz


Represents Performance Stock Units, each representing a contingent right to receive one share of the Issuer's Common Stock under the Fifth Amended and Restated 2012 Heidrick & Struggles GlobalShare Program. The Performance Stock Units will be earned in two equal increments upon the attainment of certain prescribed stock price hurdles, and will vest in equal annual installments on March 8, 2027 and 2028, subject to Ms. Heaton's continuous employment with the Issuer or an affiliate through such vesting date and the achievement of the applicable stock price hurdle for that year.


By Derek Maetzold 2020 Irrevocable Trust

By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk

By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold

By The Maetzold 2018 Remainder  Trust FBO John Derek Maetzold

By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

By DJM Grantor Retained Annuity Trust No. 5

By DJM Grantor Retained Annuity Trust No. 6

By DJM Grantor Retained Annuity Trust No. 7

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 8, 2025.

This transaction was executed in multiple trades at prices ranging from $20.00 to 20.10, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary.

Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Held by DJM Grantor Retained Annuity Trust No. 5 of which the Reporting Person is the trustee and beneficiary.

Held by DJM Grantor Retained Annuity Trust No. 6 of which the Reporting Person is the trustee and the beneficiaries are The Maetzold 2018 Remainder Trust FBO John Derek Maetzold, The Maetzold 2018
Remainder Trust FBO Emily Carol Kirk, The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold and The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold.

Held by DJM Grantor Retained Annuity Trust No. 7 of which the Reporting Person is the trustee and beneficiary.


Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over four years beginning on the date of grant at a rate of 6.25% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan.

/s/ Kris Kang, attorney-in-fact to Nicholas Rost


Common Stock, par value $0.001

Each market stock unit (MSU) represents the contingent right to receive one (1) share of Issuer common stock.

Reflects the grant of a target number MSUs subject to the award as presented in the table. The number of MSUs that ultimately vest may be 0%-200% of this number, depending upon the achievement by the Issuer of certain total shareholder return objectives.

The MSUs have four separate performance periods, which begin August 31, 2025 and end November 30, 2027, February 29, 2028, May 31, 2028 and August 31, 2028, respectively. Twenty five percent (25%) of the total award may be earned after the end of each performance period and, to the extent earned, will vest quarterly.

Market stock units do not expire; they either vest or are canceled prior to or upon the vesting date.

/s/ Kris Kang, attorney-in-fact to Melissa Ann King


Class A Common Stock

Class A Common Stock

Class A Common Stock

Shares of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company") received from the vesting of 1/12th of the restricted stock unit ("RSU") award granted on November 15, 2022.

Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.

Shares of the Company's Class A Common Stock withheld to pay applicable taxes.

Shares of Class A Common Stock of the Company received from the vesting of 1/12th of the RSU award granted on February 16, 2023.

Shares of Class A Common Stock of the Company received from the vesting of 1/3rd of 1/8th of the RSU award granted on February 16, 2023.

A total of 25,016 RSUs were originally granted on November 15, 2022, under the Company's 2017 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over three years, commencing on February 15, 2023, with 1/12th of such RSUs vesting on each quarterly vesting date so that such RSUs will be fully vested on the twelfth quarterly vesting date (November 15, 2025).

A total of 9,041 RSUs were originally granted on February 16, 2023, under the Company's 2017 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over three years, commencing on May 16, 2023, with 1/12th of such RSUs vesting on each quarterly vesting date so that such RSUs will be fully vested on the twelfth quarterly vesting date (February 16, 2026).

A total of 15,069 RSUs were originally granted on February 16, 2023, under the Company's 2017 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over three years, commencing on May 16, 2023, with (i) 1/8th of such RSUs vesting on each of the first four vesting dates; (ii) 2/3rds of 1/8th of such RSUs vesting on each of the successive four vesting dates; (iii) 1/3rd of 1/8th of such RSUs vesting on each of the next three successive vesting dates; and (iv) the remainder of such RSUs vesting on the twelfth vesting date (February 16, 2026).

/s/ Kelli Arman, on behalf of Surya Gummadi, by Power of Attorney


Common Stock, par value $0.001

Represents performance stock units (PSUs) awarded pursuant to the Issuer's 2023 Equity Incentive Plan for which performance criteria have been satisfied that will entitle the Reporting Person to receive one share of the Issuer's common stock per PSU upon vesting. 50% of the PSUs vest on August 15, 2025. The remaining PSUs will vest in two equal installments on August 15, 2026 and August 15, 2027, subject to continued service through each of the respective vesting dates. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan

/s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp


Common Stock, par value $0.001

Shares are owned by the Reporting Person's father-in-law; the Reporting Person's spouse was granted a power of attorney that provides for investment power over the shares.

/s/ Kris Kang, attorney-in-fact to Joshua Scutt


Common Stock, par value $0.001

/s/ Kris Kang, attorney-in-fact to Andrew Cappotelli


Common Stock, par value $0.001

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over two years beginning on the date of grant at a rate of 12.5% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's 2023 Equity Incentive Plan.

/s/ Kris Kang, attorney-in-fact to Ryan Glenn


Common Stock, par value $0.001

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on February 21, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.82 to $171.82, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 5 and 6 of this Form 4.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.83 to $172.50, inclusive.

Each market stock unit (MSU) represents the contingent right to receive one (1) share of Issuer common stock.

Reflects the grant of a target number MSUs subject to the award as presented in the table. The number of MSUs that ultimately vest may be 0%-200% of this number, depending upon the achievement by the Issuer of certain total shareholder return objectives.

The MSUs have four separate performance periods, which begin August 31, 2025 and end November 30, 2027, February 29, 2028, May 31, 2028 and August 31, 2028, respectively. Twenty five percent (25%) of the total award may be earned after the end of each performance period and, to the extent earned, will vest quarterly.

Market stock units do not expire; they either vest or are canceled prior to or upon the vesting date.

/s/ Kris Kang, attorney-in-fact to Toby J. Williams


This transaction was executed in multiple trades at prices ranging from $59.00 to 59.10, inclusive.  The price reported above reflects the weighted average sales price.  The reporting person hereby undertakes to provide the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

/s/ Stephanie Delavale, as Attorney-In-Fact for Kathryn M. Collins


Common Stock

In connection with the vesting on August 16, 2025, of 866 restricted stock units previously granted to the reporting person, the reporting person's receipt of 866 shares of common stock was deferred resulting in the reporting person's receipt instead of 866 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 866  restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

By:  Michelle S. Hickox      Attorney in Fact for      David W. Bailey


Class A Common Stock

Shares of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company") received from the vesting of 1/12th of the restricted stock unit ("RSU") award granted on February 16, 2023.

Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.

Shares of the Company's Class A Common Stock withheld to pay applicable taxes.

A total of 2,817 RSUs were originally granted on February 16, 2023 under the Company's 2017 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over three years, commencing on May 16, 2023, with 1/12th of such RSUs vesting on each quarterly vesting date so that the RSUs will be fully vested on the twelfth quarterly vesting date (February 16, 2026).

/s/ Kelli Arman, on behalf of Alina Kerdman, by Power of Attorney


Common Stock, par value $0.0001 per share

Common Stock

This option is fully vested.


By Lance E. D'Amico 2024 Irrevocable Trust

Class A Common Stock

Class A Common Stock

The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades ranging from $110.5000 to $110.8050.

This transaction was executed in multiple trades raging from $110.7100 to $110.9300.


Series C Common Stock

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025.

Reflects the weighted average sale price. The range of prices for such transaction is $43.68 to $44.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.


/s/ John F. Brown, as attorney-in-fact for Steffen Schewerda


Common Stock

In connection with the vesting on August 16, 2025, of 788 restricted stock units previously granted to the reporting person, the reporting person's receipt of 788 shares of common stock was deferred resulting in the reporting person's receipt instead of 788 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 788 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

By:  Michelle S. Hickox      Attorney in Fact for      John J. Ruzicka, Jr.


The reporting person elected, in accordance with the Registrant's 2021 Omnibus Stock and Incentive Plan, to exercise his right to have the Registrant withhold 171 shares of the Registrant's common stock to pay income taxes related to vesting of previously granted restricted stock units.

By:  Michelle S. Hickox      Attorney in Fact for      J. Kyle McVey


Common Stock

In connection with the vesting on August 16, 2025, of 1,077 restricted stock units previously granted to the reporting person, the reporting person's receipt of 1,077 shares of common stock was deferred resulting in the reporting person's receipt instead of 1,077 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 1,077  restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

By:  Michelle S. Hickox      Attorney in Fact for      T. Luke Longhofer


These shares were purchased in multiple transactions at prices ranging from $12.69 to $12.87 per
share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of
the  Issuer, or the staff of the Securities and Exchange Commission, upon request, full information
regarding the number of shares sold at each separate price within the range set forth in this
footnote.

Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 49,928 RSUs scheduled to vest on July 3, 2026; and (ii) 89,154 RSUs scheduled to vest in two equal annual installments on July 1,  2026 and 2027.

/s/ Audrey Lee, by power of atty., for Jeffrey A. Hirsch


Common Stock

In connection with the vesting on August 16, 2025, of 839 restricted stock units previously granted to the reporting person, the reporting person's receipt of 839 shares of common stock was deferred resulting in the reporting person's receipt instead of 839 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 839 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

By:  Michelle S. Hickox      Attorney in Fact for      Randall Allen Roewe


Common Stock

In connection with the vesting on August 16, 2025, of 1,919 restricted stock units previously granted to the reporting person, the reporting person's receipt of 1,919 shares of common stock was deferred resulting in the reporting person's receipt instead of 1,919 shares of deferred stock units into the First Financial Bankshares, Inc. Supplemental Executive Retirement Plan, as amended and restated effected July 26, 2022 (the "SERP"). The reporting person is therefore reporting the disposition of 1,919 restricted stock units in exchange for an equal number of deferred stock units under the SERP, which are payable upon the reporting person's termination.

By:  Michelle S. Hickox      Attorney in Fact for      Ronald D. Butler II


Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Charitable gift of shares; no market transaction occurred.

The Restricted Stock Unit ("RSU") shall vest in full and payout in Ordinary Shares on a one-for-one basis one year after the March 7, 2025 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made.

Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

Restricted Stock Units that have vested in full but whose payout has been deferred to a future date.

Restricted Stock Units granted March 20, 2019, that have vested in full but whose payout has been deferred to a future date.

Restricted Stock Units granted February 27, 2018, that have vested in full but whose payout has been deferred to a future date.

Restricted Stock Unit award granted February 28, 2017, that has vested in full but whose payout has been deferred to a future date.

Restricted Stock Units granted February 28, 2017, that have vested in full but whose payout has been deferred to a future date.

Restricted Stock Unit award granted February 23, 2016, that has vested in full but whose payout has been deferred to a future date.

This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.

This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.


Ordinary Shares

Gift of shares; no market transaction occurred.

The Restricted Stock Units ("RSU") shall vest in full and payout in Ordinary Shares on a one-for-one basis one year after the March 7, 2025 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made.


The reported transaction was effected pursuant to a prior election made by the Reporting Person to use a portion of his director compensation to purchase shares of common stock through participation in the Issuer's Dividend Reinvestment and Stock Purchase Plan.


The reported transaction was effected pursuant to a prior election made by the Reporting Person to use a portion of her director compensation to purchase shares of common stock through participation in the Issuer's Dividend Reinvestment and Stock Purchase Plan.


COMMON

COMMON

COMMON

THE TOTAL SHARES ON ORIGINAL FORM 4 REPORTED WAS INCORRECT SHOULD HAVE BEEN A TOTAL OF 530,000

TOTAL OF WARRANTS AS OF REPORTING PERIOD


Represents performance-based restricted stock units granted on November 20, 2024. The shares were earned on August 15, 2025, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3
each year on the anniversary of the grant.


The reporting person is enrolled in quarterly dividend reinvestment. The beneficially owned shares have been adjusted to reflect shares purchased through the reinvestment plan.


Common Stock

The option vests in three annual installments beginning on the first anniversary of the date of grant.


Michael E. Montifar, attorney-in-fact for Charles R. Crisp


Common Stock

Each unit represents one phantom share of common stock.

These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

/s/ Shanice A. Reid, by power of atty., for Albert Bourla


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024.


Brett Sandercock, Chief Financial Officer


Common Stock

Shares issued upon vesting of restricted stock units ("RSUs") on August 15, 2025.

Each RSU represents a right to receive one share of the issuer's common stock.

The remaining reported RSUs will vest in two equal installments on August 15, 2026 and August 15, 2027.

Jack W. Kennedy Jr., Attorney-in-Fact for Jared Deith


Common Stock

Represents award of restricted stock pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests on August 15, 2026.

Stock Options awarded pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests on August 15, 2026.


Represents forfeiture of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer.

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025.

Represents forfeiture of time-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer.

Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer.

Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer.

This total includes 375,005 RSUs with performance based vesting conditions.


Common Stock

Restricted stock units convert into an equal number of shares of common stock.

On September 17, 2024, the Reporting Person was awarded 1211.00 restricted share units vesting with respect to one third of the shares on each of August 15, 2025, August 15, 2026 and August 15, 2027.

/s/ Seth Gastwirth, attorney-in-fact for Alan K. Tse


Lisette and Michael Farrell Family Trust

Represents performance-based restricted stock units granted on November 20, 2024. The shares were earned on August 15, 2025, when the compensation committee certified that the performance metrics were met. Stock units vest1/3
each year on the anniversary of the grant.

Michael J. Farrell, Chief Executive Officer


/s/ Sara V. Ponessa, as attorney-in-fact for Jacqueline Scanlan


Common Units (Limited Partner Interests)

The Reporting Person is a Director of MPLX GP LLC, the general partner of the Issuer.  The Issuer is managed by the directors and executive officers of MPLX GP LLC.

/s/ Molly R. Benson, Attorney-in-Fact for John P. Surma


/s/ Brandon Brunet, Attorney-in-Fact for Daniel J. McHenry


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock.

On August 15, 2023, the reporting person was granted an award of restricted stock units, vesting in three equal annual installments on the first anniversary date of the grant (August 15, 2024) and the second anniversary date of the grant (August 15, 2025) and the third anniversary date of the grant (August 15, 2026)

On March 28, 2024, the reporting person was granted an award of restricted stock units (RSUs) under the Citizens, Inc. Omnibus Incentive Plan for 2023 pay-for-performance. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 28, 2025) and the second anniversary of the date of the grant (March 28, 2026) and the third anniversary of the date of the grant (March 28, 2027).

On March 28, 2024, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2024 long-term incentive.  The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 28, 2025) and the second anniversary of the date of the grant (March 28, 2026) and the third anniversary of the date of the grant (March 28, 2027).

On March 31, 2025, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2025 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2026) an dthe second anniversary of the date of the grant (March 31, 2027) and the third anniversary of the date of the grant (March 31, 2028).


/s/ Molly R. Benson, Attorney-in-Fact for J. Michael Stice


This figure does not include 103,530 shares held directly by Mr. Stahl.

For each indirect account, Mr. Stahl disclaims beneficial ownership except to the extent of his pecuniary interest, if any.


/s/ Molly R. Benson, Attorney-in-Fact for Frank M. Semple


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

These shares were purchased through the Citizens, Inc. Stock Investment Plan as part of regular monthly payroll deduction.

On March 31, 2025, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2024 pay-for-performance. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2026) an dthe second anniversary of the date of the grant (March 31, 2027) and the third anniversary of the date of the grant (March 31, 2028).


By Garry L. Peiffer Revocable Trust.

/s/ Molly R. Benson, Attorney-in-Fact for Garry L. Peiffer


These shares were retained by the Issuer in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of an installment of the restricted stock units. The amount retained by the Issuer was not in excess of the amount of the tax liability.

/s/ Tracy Feanny, Attorney in Fact For: Esam Elashmawi


/s/ Molly R. Benson, Attorney-in-Fact for Christopher A. Helms


Common Stock

Common Stock

Information previously reported to the SEC on Shareholder's Form 3 filed on January 19, 2024.

represents shareholder's 32.75% contribution interest to RAC Merger LLC, which currently holds 16,033,253 shares of the Issuers Common Stock and 100,000 shares of the Issuers Series A Preferred Stock.


/s/ Molly R. Benson, Attorney-in-Fact for Christine S. Breves


Common Stock

Common Stock

Information previously reported to the SEC on Shareholder's Form 4 filed on July 8, 2022.


Common Stock

Common Stock


represents shareholder's post 1:125 reverse split amount originally reported on shareholder's form 3/A filed on March 28, 2022 in the pre 1:125 reverse split amount.

represents shareholder's 1.75% contribution interest to RAC Merger LLC, which currently holds 16,033,253 shares of the Issuers Common Stock and 100,000 shares of the Issuers Series A Preferred Stock.


Common Stock

Includes .250278 shares acquired pursuant to dividend reinvestment and not previously reported pursuant to Rule 16a-11.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Includes 1.04 shares acquired pursuant to dividend reinvestment and not previously reported pursuant to Rule 16a-11.

This option, in the amount of 10,879, is exercisable as follows: 3,626 shares on March 1, 2020, and 7,253 shares on December 28, 2020.

Chief Legal Officer and Corporate Secretary

/s/ Shane T. Pfleiderer, Attorney-in-Fact for Molly R. Benson


By FMTC Custodian - Roth IRA FBO Eric W. Roberts

By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA

By IRA Financial Trust Company CFBO Eric W. Roberts

The weighted average purchase price for the transaction reported was $2.8977, and the range of prices were between $2.80 and $2.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.


/s/ John J. Boczar, Attorney-in-fact for John D. Cox


Common Stock

Represents award of restricted stock pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan.  Vests in equal installments of 25% per year beginning on August 15, 2026.

Stock Options awarded pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan.  Vests in equal installments of 25% per year beginning on August 15, 2026.


Represents the purchase of shares in open market.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.65 to $41.87, inclusive. The reporting person undertakes to provide to TTM Technologies, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price reported in the second line is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.65 to $40.99, inclusive. The reporting person undertakes to provide to TTM Technologies, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Common Stock

Represents award of restricted stock pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests in equal installments of 25% per year beginning on August 15, 2026.

Stock Options awarded pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests in equal installments of 25% per year beginning on August 15, 2026.


ResMed Common Stock

This transaction was executed in multiple trades at prices ranging from $286.90 - $287.24. The price reported above reflects the weighted average sale price.

Represents the date options become exercisable.  Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.


On December 18, 2024, Horizon Kinetics Asset Management LLC (HKAM) filed an amendment to its Schedule 13D, in which it noted beneficial ownership of 3,578,173 shares and Murray Stahl's direct interest in 7,848 shares and his indirect interest in approximately 156,083 shares. The extent of HKAM's pecuniary interest in the shares beneficially owned is disclosed herein. Mr. Stahl does not exercise investment discretion with respect to the securities of the Issuer.


Common Stock

Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of MKS Inc.

These shares were withheld by MKS Inc. to satisfy the tax withholding obligations triggered by the vesting of RSUs and do not represent a discretionary trade by the reporting person.

These RSUs vest in two installments, 60% of which shall vest on August 17, 2024 and 40% of which shall vest on August 17, 2025; provided that if, in any vesting year, August 17th is not a business day, such vesting shall occur on the next business day.

/s/ M. Kathryn Rickards, attorney-in-fact


Common Stock


Common Stock

Represents award of restricted stock pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests on August 15, 2026.

Stock Options awarded pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests on August 15, 2026.


Represents shares withheld to satisfy taxes; no shares were sold.


Received ordinary shares pursuant to a gift from the Sponsor.


Represents the total number of ordinary shares transferred as a gift to directors and officers of the Issuer.

Includes a total of 240,848 ordinary shares underlying the private units acquired by the Reporting Person upon the closing of the Issuer in the public offering.

UY Scuti Investments Limited, By: /s/ Guojian Zhang


Represents performance-based restricted stock units granted on November 20, 2024. The shares were earned on August 15, 2025, when the compensation committee certified that the performance metrics were met. Stock units vest
1/3 each year on the anniversary of the grant.

Michael J. Rider, Global General Counsel and Secretary


Degner Terri L

C/O FS BANCORP, INC. 6920 220TH STREET S

Common Stock

Represents award of restricted stock pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests in equal installments of 33.34% per year beginning on August 15, 2026.

Shares held jointly with spouse.

Stock Options awarded pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan. Vests in equal installments of 33.34% per year beginning on August 15, 2026.


Common Stock

Represents award of restricted stock pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan.  Vests on August 15, 2026.

Stock Options awarded pursuant to the FS Bancorp, Inc. 2018 Equity Incentive Plan.  Vests on August 15, 2026.


Common Stock

Represents the vesting of Restricted Stock Units.

Restricted Stock Units convert into common stock on a one-for-one basis.

Represents shares withheld for taxes in connection with the vesting of Restricted Stock Units.

The Restricted Stock Units vested on August 15, 2025.

/s/ Elizabeth C. Southern, Attorney-in-Fact


On 8/15/25, the reporting person separated from the company. This will be the final reportable event as there have been no opposite way transactions in the past 6 months.  Any remaining restricted stock units were forfeited upon separation and have been removed from their beneficial ownership.

On 8/15/25, 8,230 shares vested from a restricted stock unit award. The shares noted above were withheld from the vesting to cover the reporting person's estimated tax obligation.

/s/ Francis K. Lee, by Brandon Rykkeli, attorney-in-fact


Co-trustee of Trusts created by Estate of Howard O. Woltz, Jr.

Common Stock


Common Stock, par value $0.0001 per share

Award represents a stock option grant that was originally scheduled to vest on 12/11/2021, but for which vesting was accelerated to 10/31/2021 upon Mr.  Horlock's initial retirement.


Represents weighted average price.

Mr. Shaw has investment power over 500,000 shares as Trustee for the benefit of a family member. Mr. Shaw has voting control over the remainder of the shares pursuant to a voting agreement.

The Rule 10b5-1 Plan's date of adoption was August 22, 2024.


Reflects weighted average price. Range of prices were between $42.25 to $42.585. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.


MacKenzie Realty Capital Inc. Common Stock

Amended to reflect correct number of shares.

MacKenzie Real Estate Advisers, LP ("MREA") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MREA and therefore could be deemed to beneficially own the MRC shares acquired by MREA, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

MPF Successors, LP ("MPF") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MPF and therefore could be deemed to beneficially own the MRC shares acquired by MPF, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

/s/ Jeri Bluth, as attorney-in-fact for Robert Dixon


Common Stock

Represents award of restricted stock pursuant to the FS Bancorp. Inc. 2018 Equity Incentive Plan. Vests in equal installments of 25% per year beginning on August 15, 2026.

Stock Options awarded pursuant to the FS Bancorp. Inc. 2018 Equity Incentive Plan. Vests in equal installments of 25% per year beginning on August 15, 2026.


Phantom Stock ONB Executive Deferred Compensation Plan

Common Stock

Shares of phantom stock acquired under the Old National Bancorp Executive Deferred Compensation Plan (the "Plan") represent shares of Old National Bancorp common stock on a 1-for-1 basis and are payable in cash upon distribution to the Reporting Person in accordance with the terms of the Plan.

/s/ Sharon K. Brantley, Paralegal, as Attorney-In-Fact for James A. Sandgren


Revocable trust in which Geoffrey Parker and Jill Parker are the trustees.

Geoffrey M. Parker Roth IRA.

/s/ Diana Witt, attorney-in-fact for Mr. Geoffrey Parker


/s/ Lori A. Castillo, By Power of Attorney


/s/ Diana Witt, attorney-in-fact for Mr. Eduardo Bezerra


Andy D. Waters By: Cynthia L Adkins, Attorney-in-Fact Stock Transfer Administrator


Common Stock


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents shares held in the Timberland Bank Employee Stock Ownership and 401(k) Plan ("KSOP")

/s/Cheryl Parks, Power of Attorney for Breanne D. Antich


Shares traded back to the Company to cover tax liability for vested stock awards.


This represents a bona fide gift. Mrs. Diddell disclaims all beneficial and pecuniary interests.

/s/ Robert J. Ben, attorney-in-fact for Wendy Diddell


By the McKesson Corporation 401(k) Retirement Savings Plan

Sale pursuant to a previously adopted plan dated November 8, 2024, in compliance with Rule 10b5-1(c).


As Custodian for child under the UTMA/PA

/s/ James M. Bone, Jr. as Attorney-in-Fact for Richard S. Lochen Jr.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Represents restricted stock units that vest in four equal annual installments beginning on August 18, 2026, subject to the reporting person's continued employment on the applicable vesting date.

These options will become 100% vested and exercisable on August 18, 2029, subject to the reporting person's continued employment on the applicable vesting date.


Common Stock

Common Stock

Common Stock

/s/ Ralph M. Gallo, Jonathan D. Hill, Power of Attorney


Common Stock

Common Stock

Common Stock

Common Stock

Includes 368.66 shares of common stock held in the Kennametal Inc. 401(k) Plan

1 for 1

Restricted stock units are subject to time-based vesting and are disbursed in three equal annual installments commencing on the first anniversary date of the grant date, subject to continued employment with the company

Michelle R. Keating, as attorney-in-fact for Patrick Watson


Common Stock

Common Stock

Common Stock

Common Stock

1 for 1

Restricted stock units are subject to time-based vesting and are disbursed in three equal installments commencing on the first anniversary date of the grant

Michelle R. Keating, as attorney-in-fact for Lorraine M. Martin


Common Stock

Common Stock

Common Stock

Common Stock

Includes 76.74 shares of common stock held in the Kennametal Inc. 401(k) Plan

1 for 1


Common Stock

Common Stock

Common Stock

Common Stock

Includes 1,198.288 shares acquired through Kennametal Inc.'s dividend reinvestment plan, meeting the requirements of Rule 16a-11 of the Securities and Exchange Act of 1934, as amended, since the reporting person's last Form 4 filing

1 for 1

Michelle R. Keating, as attorney-in-fact for William J. Harvey


Held of record by the Kenneth M. Young Revocable Trust U/A 5/8/15.

/s/ John J. Dziewisz, attorney-in-fact for Kenneth M. Young


Common Stock

Common Stock

Common Stock

Common Stock

1 for 1

Michelle R. Keating, as attorney-in-fact for Cindy L. Davis`


Common Stock

Common Stock

Common Stock

Common Stock

Includes  455.24 shares held in the Kennametal Inc. 401(k) Plan

1 for 1

Michelle R. Keating, as attorney-in-fact for Sanjay K. Chowbey


The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.5050 to $0.5500, inclusive. The reporting person undertakes to provide XBP Global Holdings, Inc., any security holder of XBP Global Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Mr. Klein is an employee of Avenue Capital Management II, L.P. ("Avenue") or one of its affiliates. Avenue and certain of its affiliates may be deemed to beneficially own securities of the Issuer. Mr. Klein expressly disclaims beneficial ownership of any securities of the Issuer that may be deemed to be beneficially owned by Avenue or its affiliates.


Restricted stock award granted under the Kelly Services Equity Incentive Plan. Shares vest in equal increments over two years, commencing on the anniversary of the grant date.

/s/ Cynthia D. Mull, attorney-in-fact for Ms. Browning


Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on August 15, 2027, and 50% will vest on August 15, 2028.

Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact


Common Shares

Common Shares

Series A Common shares are convertible, on a share-for-share basis, into common shares.

Gift to children

Reporting person is one of four trustees of a Voting Trust which is record owner of these Series A Common shares and which files its holdings on a Form 4.  The shares reported are held by respective reporting person and her family members that have a pecuniary interest in such shares.  Reporting person already reports children's ownership in the Voting Trust.  Accordingly, the gift not result in a change in the number of securities reported as beneficially owned by reporting person.  Includes 756,243 Series A Common Shares held by a family partnership of which reporting person is a general partner.


Common Stock

Common Stock

Common Stock

Common Stock

Includes 2,157.38 shares of common stock held in the Kennametal Inc. 401(k) Plan

1 for 1

Michelle R. Keating, as attorney-in-fact for Judith L. Bacchus


Common Stock

Common Stock

Common Stock

Common Stock

Includes 712.292 shares acquired through Kennametal Inc.'s dividend reinvestment plan, meeting the requirements of Rule 16a-11 of the Securities and Exchange Act of 1934, as amended, since the reporting person's last Form 4 filing

1 for 1

Michelle R. Keating, as attorney-in-fact for Joseph Alvarado


Common Stock

Common Stock

Common Stock

Common Stock

1 for 1

Michelle R. Keating, as attorney-in-fact for William Lambert


Represents open market purchases.

Shares were purchased in two transactions, each executing at $1.10 per share.  Reporting Party agrees to provide details of the transactions to the SEC upon request.


The transaction reported reflects the withholding of restricted stock units in satisfaction of the reporting person's tax liability. The restricted stock units were granted to the reporting person on August 15, 2022 pursuant to the company's 2017 Equity Incentive Plan in accordance with the company's long-term compensation program and vested on August 15, 2025, together with accrued dividend equivalents.

The transaction reported reflects the cash settlement of fractional shares in connection with the vesting of restricted stock units, as described in the previous footnote.

/s/ Ariel E. Greenstein, Attorney-in-Fact for Rajesh Pankaj


Common Stock

Options vest in equal annual installments on each of the first three anniversary dates of the grants

PSUs vest in total at the end of the three year anniversary date of the grant


Common Stock


Common Stock

Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants


Common Stock

Common Stock

Options and RSUs vest in equal annual installments on each of the first four anniversary dates of the grants


Class A Ordinary Shares, par value $0.05 per share

Represents Issuer's Class A ordinary shares issued pursuant to restricted share units granted to the Reporting Person under the Issuer's 2017 share incentive plan.

The securities are directly held by Lorri Kelley Advisors, Inc. Lorri A. Kelley ("Mrs. Kelley") is the sole shareholder and sole director of Lorri Kelley Advisors, Inc. Therefore, Mrs. Kelley may be deemed to be an indirect beneficial owner of the securities held by Lorri Kelley Advisors, Inc. This report shall not be deemed an admission that any of the reporting persons is the beneficial owner of such securities for purposes of Section 16 of Securities Exchange Act of 1934, as amended, or for any other purpose.

1. Mrs. Kelley serves on the board of directors of the Issuer until August 16, 2025.


Shares held by Sander Electronics, a controlled affiliate of Mr. Huang.

Shares held by SANDER ELECTRONIC CO., LTD., a controlled affiliate of Mr. Huang.

Shares held by INWOOD HOLDING LIMITED, a controlled affiliate of Mr. Huang.

/s/ Gianas Randy Harrison, as Attorney-in-Fact


Common Stock

1 for 1

Restricted stock units are subject to time-based vesting and are disbursed in three equal installments commencing on the first anniversary date of the gran

Michelle R. Keating, as attorney-in-fact for Douglas T. Dietrich


Orrstown Financial Services, Inc, Common Stock

Orrstown Financial Services, Inc., Common, Rest. Stock. Unt.

Orrstown Financial Services, Inc. Common, Restricted Stock

Includes 27,849 shares owned jointly with the reporting persons spouse

Restricted stock units vesting three years after the date of the award based on pre-established company performance criteria.

Time-vested restricted stock with various vesting dates over the next three years


Common Stock

1 for 1

The stock credits become payable in common stock on January 1, 2028

Michelle R. Keating, as attorney-in-fact for Sagar A. Patel


As Trustee, Baileys Grandchildren's Trust FBO Jeremy Baileys

As Trustee, Baileys Grandchildren's Trust FBO Alison Brooke Baileys

Series D 8% Cumulative Conver Redeemable Preferred Shares

At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.


Grant of restricted stock that was awarded to the Reporting Person as an inducement to his employment with Regional Health Properties, Inc. ("Regional"). The restricted stock will vest in three substantially equal installments on August 14, 2025, August 14, 2026 and August 14, 2027.

At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional, each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

Owned by CareVest Capital, L.L.C. ("CareVest"). Mr. Thornton owns 100% of the outstanding voting shares of CareVest and is reporting CareVest's total direct holdings of Regional shares.


Common Stock

1 for 1

Michelle R. Keating, as attorney-in-fact for Shelley J. Bausch


Common stock, $0.001 par value per share

/s/ Stefanie C. Fleischmann, as attorney-in-fact for Amanda Fabiano


Common stock, $0.001 par value per share

The Reporting Person received restricted stock units subject to a three-year vesting schedule, vesting in three equal installments upon each of the first three anniversaries of August 16, 2023, in each case subject to the Reporting Person's continued employment or service with the Issuer through each such date.

Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, $0.001 par value per share.

The restricted stock units vest in three equal installments upon each of the first three anniversaries of August 16, 2023, subject to the Reporting Person's continued employment or service with the Issuer through each such date.

/s/ Stefanie C. Fleischmann, as attorney-in-fact for William J. Tanimoto


Common Stock

Common Stock

Common Stock

1 for 1

Restricted stock units are subject to time-based vesting and are disbursed in three equal installments commencing on the first anniversary date of the grant

Michelle R. Keating, as attorney-in-fact for Paul Sternlieb


See Exhibit 99.1.

See Exhibit 99.1


Common Stock

Common Stock

Common Stock

Common Stock

1 for 1

Michelle R. Keating, as attorney-in-fact for Stev


Common Stock

Common Stock

Award of restricted stock units ("RSUs") pursuant to the Ralliant Corporation 2025 Stock Incentive Plan and subject to time-based vesting provisions.

RSUs are payable in shares of common stock on a one-to-one basis.

Amount includes 8,891 shares of Issuer common stock received as a dividend in connection with the separation (the "Separation") of the Issuer from Fortive Corporation ("Fortive") and 148,884 RSUs that were converted from unvested RSUs previously issued by Fortive and were received by the Reporting Person in connection with the Separation.

50% of the options vest on the first anniversary of the grant date and 25% of the options vest on each of the second and third anniversaries of the grant date.

50% of the options vest on each of the third and fourth anniversaries of the grant date.


Amount includes 32,858 RSUs that were converted from unvested RSUs previously issued by Fortive Corporation ("Fortive") and were received by the Reporting Person in connection with the separation of the Issuer from Fortive.

Transaction represents the aggregate withholding of shares for tax purposes in connection with the vesting and distribution on August 15, 2025 of certain RSUs that were converted from RSUs previously issued by Fortive.


Amount includes 13,016 RSUs that were converted from unvested RSUs previously issued by Fortive Corporation ("Fortive") and were received by the Reporting Person in connection with the separation of the Issuer from Fortive.


Amount includes 15,185 RSUs that were converted from unvested RSUs previously issued by Fortive Corporation ("Fortive") and were received by the Reporting Person in connection with the separation of the Issuer from Fortive.


Amount includes 1,681 shares of Issuer common stock received as a dividend in connection with the separation (the "Separation") of the Issuer from Fortive Corporation ("Fortive") and 22,167 RSUs that were converted from unvested RSUs previously issued by Fortive and were received by the Reporting Person in connection with the Separation.


Common Stock

Common Stock

Options vest in four equal annual installments beginning on the first anniversary of the grant date.


Ordinary Shares

Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU.

The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.


Ordinary Shares


Ordinary Shares

The RSUs will vest in full on January 1, 2027, subject to the Reporting Person's continued service through such date.


Ordinary Shares

On August 18, 2025, the Reporting Person purchased 7,692 ordinary shares of the Issuer in a private placement transaction directly with the Issuer. The purchase was effected pursuant to Rule 16b-3(d), the result of which is that such acquisition is exempt from the provisions of Section 16(b) and the rules promulgated thereunder.


Represents shares of restricted common stock, vesting on the date of the grant, granted pursuant to the Second Amended and Restated La Rosa Holdings Corp. 2022 Equity Incentive Plan.


Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Includes 60,844 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.

Includes 58,907 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.

Includes 54,220 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact


Includes 103,132 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2025.

Includes 98,757 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Includes 93,757 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.


Includes 243,943 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Includes 233,318 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.

Includes 219,881 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.


Non-qualified Stock Option (Right to Buy)

Common Stock

Common Stock

Common Stock

Common Stock

The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.

Sales prices for the transactions reported here range from $117.91 to $118.89.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Sales prices for the transactions reported here range from $118.91 to $119.01.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request.

Sales prices for the transactions reported here range from $117.91 to $118.85.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Sales prices for the transactions reported here range from $118.95 to $118.98.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

/s/ Edward S. Son by Power of Attorney for Johanna Mercier


The shares reported in this transaction represent a gift to a Donor Advised Fund.

These shares are held directly by The Freedom Revocable Trust dated February 28, 2017 as amended, and for which the Reporting Person serves as trustee.

A portion of these securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

/s/ Mark Reinstra Attorney-in-Fact for David Baszucki


Represents shares of common stock gifted by the reporting person.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.25 to $22.02, inclusive. The reporting person sold these shares as they related to restricted stock that vested on August 18, 2025, which also covered tax owing related to the vesting of this restricted stock. The reporting person undertakes to provide to Contango ORE, Inc., any security holder of Contango ORE, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.


Sales were affected pursuant to Rule 10b5-1 trading plan dated 12/23/2024.

Reflects the weighted average sales price with transactions in a range of sales from $89.7500 to $91.6500. Upon request by the SEC, full information regarding the number of shares sold at each separate sales price will be provided.

Shares reported include unvested Restricted Stock Units (RSUs) and Performance Stock Units (PSUs).

By: Michelle Rankin For: David M Rothenstein


Common Stock

Common Stock

Each performance stock unit represents a right to receive one share of the Issuer's common stock.

This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date.

Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.


Common Stock

Common Stock


Sales were effected pursuant to Rule 10b5-1 trading plan dated 09/06/2024.


Shares traded back to the Company to cover tax liability for vested stock awards.


Sales were effected pursuant to Rule 10b5-1 trading plan dated 9/11/2024.

Reflects the weighted average sales price with transactions in a range of sales from $89.5300 to $91.6675. Upon request by the SEC, full information regarding the number of shares sold at each separate sales price will be provided.


Class A Common Stock

Represents restricted stock units ("RSUs") that were granted under the Issuer's Amended and Restated 2020 Incentive Award Plan on March 1, 2025, and vested in full on August 15, 2025. Shares of Class A common stock of the Issuer were delivered to the Reporting Person in settlement of vested RSUs on August 15, 2025.

Each RSU represents the contingent right to receive one share of Class A common stock of the Issuer.

Represents shares of Class A common stock that have been withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on August 15, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.


Class A Common Stock


Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 23, 2024, to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

The weighted average sale price for the transaction reported was $2.7286, and the range of prices were between $2.60 and $2.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.


Common Stock

Common Stock

Common Stock

Exercise and sale of shares pursuant to a Rule 10b5-1 plan adopted by Mr. Fauber on July 30, 2024.

One fourth of the options vest each year beginning with the date indicated.

Elizabeth McCarroll, by power of attorney for Robert Fauber


Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

/s/ Matthew K. Diamond, Attorney-in-Fact for Mimi K. Drake


/s/ Matthew K. Diamond, Attorney-in-Fact for Robert G. Pearse


The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.635 to $32.00. The Reporting Person undertakes to provide to Resideo Technologies, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4.

These securities are owned directly by CD&R Channel Holdings II, L.P. ("CD&R Holdings II"). CD&R Investment Associates XII, Ltd. ("CD&R Holdings GP") is the general partner of CD&R Holdings II and may be deemed to beneficially own the reported securities. Investment and voting decisions with respect to the reported securities are made by majority vote of an investment committee (the "Investment Committee") of limited partners of CD&R Associates XII, L.P. ("CD&R Associates"), which may be deemed to beneficially own the reported securities. Each of CD&R Holdings GP and CD&R Associates, as well as each member of the Investment Committee, expressly disclaims beneficial ownership of the reported securities, except to the extent of their respective pecuniary interest therein.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.045 to $32.00.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.37 to $31.855.


/s/ Matthew K. Diamond, Attorney-in-Fact for Connia M. Nelson